A novel assay for exosomal and cell-free miRNA isolation and quantification

Area of Science:

• Biochemistry
• Molecular Biology
• Nanotechnology

Background:

• MicroRNAs (miRNAs) in exosomes show promise as disease biomarkers and therapeutic targets.
• Current commercial methods for exosome and miRNA isolation have limitations in yield and purity.
• A need exists for improved, clinically applicable techniques for exosome and miRNA analysis.

Purpose of the Study:

• To develop and validate a novel, high-performance method for exosome enrichment and miRNA extraction from biofluids.
• To compare the developed method with existing commercial techniques for exosome and miRNA isolation.
• To optimize reagents and parameters for robust miRNA quantification via RT-qPCR.

Main Methods:

• Exosome purification using a novel mannuronate-guluronate polymer (MGP) to prevent plasma protein co-precipitation.
• miRNA extraction employing a combination of chaotropic and non-chaotropic salts, avoiding hazardous chemicals.
• Quantitative reverse transcription polymerase chain reaction (RT-qPCR) for miRNA detection, with optimized chemistry and TaqMan probes.
• Characterization of isolated exosomes using Western blot, Nanoparticle Tracking Analysis (NTA), and confocal microscopy.

Main Results:

• The MGP-based method successfully isolated exosomes with high quality, concentration, and biological activity.
• The developed miRNA extraction protocol efficiently isolated miRNAs from plasma, serum, and exosomes.
• Optimized RT-qPCR demonstrated high sensitivity, efficiency, and linearity for miRNA quantification.
• The new procedure outperformed commercial techniques in terms of exosome and miRNA yield and quality.

Conclusions:

• The developed MGP-based exosome enrichment and miRNA extraction method provides a high-performance solution for clinical applications.
• This technique enables accurate measurement of cell-free and exosomal miRNAs in various body fluids.
• The optimized protocol addresses the limitations of current commercial methods, paving the way for advanced miRNA-based diagnostics and therapeutics.